Today, the House Energy and Commerce Health Subcommittee held a hearing to examine legislation to improve the Medicare Part B Drug Program. Included in the discussion was the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013 (H.R.1428). Testimony was given highlighting the importance of this legislation, which continues Medicare coverage of immunosuppressive drugs for the life of a kidney transplant.
The National Kidney Foundation submitted the following written testimony, which will be entered into the committee hearing record.
The National Kidney Foundation (NKF) is pleased that the Committee is holding a hearing today on legislation to help kidney transplant recipients obtain access to medications that are required to help maintain the viability of the transplanted kidney. NKF is America’s largest and oldest health organization dedicated to the awareness, prevention and treatment of kidney disease for millions of patients and their families and for tens of…
View original post 514 more words